Solv, a provider of same-day and next-day appointment software for health care providers, raises $45M Series C co-led by Acrew Capital and Corner Ventures
Context & Ripple Effects
Solv's raise extends a run of backing from its $27M Series B+ led by Acrew Capital in late 2020 — Acrew returning to co-lead this round alongside Corner Ventures signals continuity rather than a new thesis. The company sells same-day and next-day appointment software to health care providers, with its customer base rooted in urgent care clinics per earlier coverage.
The round lands amid steady venture interest in tools that route patients into care: Solace's later $130M raise at a $1B valuation for patient advocacy matching shows the broader navigation category drawing nine-figure checks.
First-order effects
- Solv gets fresh capital to scale same-day/next-day scheduling across provider customers concentrated in urgent care, with Acrew Capital and Corner Ventures taking board-level conviction via a co-led Series C.
Second-order effects
- Urgent care operators adopting real-time scheduling raise the bar for patient-management vendors that still rely on call-based booking, pressuring rivals in Solv's adjacent software stack to add instant-availability features.
Third-order effects
- If funding keeps flowing into patient-routing software — from Solv's scheduling to Solace's advocacy matching — access layers could consolidate into the default front door for care, with clinics competing on visibility inside these platforms.
The trend: Health care access software — scheduling, navigation, advocacy — is attracting successive larger venture rounds as it becomes the entry point between patients and providers.